26 May 2023
The evidence behind which drugs to use in rheumatoid arthritis can be limited – but what does the day-to-day practice show us about the safety and efficacy of these treatments?
In this Rheumatology Journal Watch, Dr Deepak Jadon speaks to Dr Thomas Frisell, epidemiologist at the Karolinska Institutet, Stockholm, Sweden. They take us through the results of the Anti-Rheumatic Therapies in Sweden programme, a 20-year study of how antirheumatic drugs are used in clinical practice.